Ark Invest's Strategic AI Moves: Tempus AI Acquisition Spree Amid Tech Sector Volatility

Cathie Wood's Ark Invest Continues To Load Up On Tempus AI, Dumps Bitcoin-Focused Block In Tech Meltdown Aftermath - ARK Innovation ETF (ARCA:ARKK)

On Tuesday, Cathie Wood's Ark Invest executed notable trades, including significant activity involving Tempus AI Inc. TEM, Block Inc. XYZ, and DraftKings Inc. DKNG. These trades come amid a backdrop of market volatility and strategic repositioning by Ark Invest. The Tempus AI Trade Ark Invest's ARK Innovation ETF ARKK made a substantial purchase of 94,251 shares of Tempus AI, valued at approximately $4.29 million, based on the closing price of $45.58. Tempus AI recently reported its fourth-quarter earnings, revealing a revenue miss but an earnings-per-share beat. Despite the revenue shortfall, the company provided strong guidance, which may have influenced Ark's decision to increase its stake. In a recent market environment characterized by a tech sector downturn, Ark has been actively acquiring shares in companies like Tempus AI. Amid Monday's tech stock meltdown, Wood had acquired Tempus AI stock worth $13.23 million. The Block Trade On the same day, Ark Invest's ARKK ETF sold 203,659 shares of the Bitcoin BTC/USD-focused company Block -- amounting to approximately $11.26 million at the closing price of $55.29. Block's recent earnings report showed a revenue miss. Despite the revenue miss, Block's CEO, Jack Dorsey, remains optimistic about achieving a "Rule of 40" run rate by the end of the year. The DraftKings Trade Ark Invest also reduced its holdings in DraftKings by selling 23,195 shares from the ARK Next Generation Internet ETF ARKW, valued at approximately $896,718, based on the closing price of $38.66. DraftKings recently reported its fourth-quarter earnings, which included a revenue miss during a challenging period for the sports betting industry. Despite the revenue miss, analysts have highlighted DraftKings' resilience and potential for future growth. Other Key Trades: Sold shares of Roku (ROKU) from the ARKF, ARKQ, and ARKK. Bought shares of Ibotta Inc. (IBTA) for the ARKF and ARKW. Sold shares of Roblox Corp. (RBLX) from the ARKF, ARKK, and ARKW ETFs. Sold shares of CareDx Inc. (CDNA) from the ARKG ETF. Bought 6,495 shares of CRISPR Therapeutics AG CRSP for the ARKK and ARKG ETFs. Image via Shutterstock Read Next: Trump Turns White House Into Tesla Showroom, Says Elon Musk Was 'Treated Very Unfairly' -- Here's The Car He Picked For Himself This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal $BTCBitcoin$83107.500.23%OverviewARKKARK Innovation ETF$48.571.48%ARKWARK Next Generation Internet ETF$93.592.18%CRSPCRISPR Therapeutics AG$42.50-1.94%DKNGDraftKings Inc$38.663.81%TEMTempus AI Inc$46.202.28%XYZBlock Inc$55.651.66%Market News and Data brought to you by Benzinga APIs

Cathie Wood's Wednesday Moves: Ark Pours $1.36 Million Into Tempus AI Shares Following Deep 6 AI Acquisition, Offloads Rocket Lab Stock - ARK Autonomous Technology & Robotics ETF (BATS:ARKQ), ARK Innovation ETF (ARCA:ARKK)

On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. TEM and Rocket Lab USA Inc. RKLB. The Tempus AI Trade Ark Invest's ARK Innovation ETF ARKK acquired 29,845 shares of Tempus AI, valued at approximately $1.36 million, based on the closing price of $45.50. This purchase aligns with Ark's ongoing strategy to bolster its position in innovative technology sectors. Tempus AI recently announced its acquisition of Deep 6 AI, a move expected to enhance its network with over 750 provider site locations and access to more than 30 million patients. This acquisition is anticipated to strengthen Tempus AI's market presence and capabilities. Furthermore, Tempus AI's recent earnings report revealed a revenue miss but an earnings-per-share beat, coupled with strong future guidance. The strategic acquisition of Deep 6 AI and the positive earnings outlook underscore Tempus AI's potential for growth, making it an attractive investment. Wood has been loading up on Tempus AI stock in recent days. On Tuesday, Ark purchased $4.29 million worth of stock, while on Monday, amid the tech meltdown, the firm had scooped up stock worth $13.23 million. The Rocket Lab Trade Ark Invest also made notable moves involving Rocket Lab. The ARK Autonomous Technology & Robotics ETF ARKQ and ARK Space Exploration & Innovation ETF ARKX collectively sold 41,839 shares of Rocket Lab, valued at approximately $771,092, based on the closing price of $18.43. This sale comes amid Rocket Lab's recent announcement of being selected by Airbus SE to supply solar panels for 100 OneWeb Low Earth Orbit satellites, a development that has positively impacted Rocket Lab's stock price. Additionally, Rocket Lab recently inked a non-binding term sheet to acquire a controlling stake in Mynaric AG for $75 million, with an additional earn-out tied to future revenue targets. This acquisition aims to enhance Rocket Lab's satellite technology capabilities, further solidifying its position in the aerospace sector. Other Key Trades: Sold 9,961 shares of CareDx Inc (CDNA) from ARKG. Bought 8,890 shares of CRISPR Therapeutics AG (CRSP) for ARKK and 1,781 shares for ARKG. Bought 15,095 shares of Intellia Therapeutics Inc (NTLA) for ARKK and 3,025 shares for ARKG. Bought 4,847 shares of AeroVironment Inc (AVAV) for ARKQ and 3,093 shares for ARKX. Image via Shutterstock Read Next: This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal ARKKARK Innovation ETF$49.913.57%Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock - anytime. Reveal Full ScoreEdge RankingsMomentum-Growth-Quality-Value-Price TrendShortMediumLongOverviewARKQARK Autonomous Technology & Robotics ETF$67.222.03%ARKXARK Space Exploration & Innovation ETF$18.231.73%RKLBRocket Lab USA Inc$18.543.98%TEMTempus AI Inc$46.251.47%Market News and Data brought to you by Benzinga APIs

Cathie Wood's ARK buys Tempus, GitLab stock, sells Roku, Roblox By Investing.com

In a series of strategic trades, Cathie Wood's ARK Investment Management LLC executed a variety of buy and sell orders on Thursday, March 6th, 2025, reflecting the firm's dynamic investment approach. The most significant purchase of the day involved Tempus AI Inc (NYSE:TEM), with ARK acquiring a total of 270,802 shares across its ARKK and ARKG ETFs, amounting to a staggering $14,368,754. This move underscores ARK's growing interest in the artificial intelligence sector, particularly in companies like Tempus AI that are at the forefront of integrating AI with healthcare. Another major buy was GitLab Inc (NASDAQ:GTLB), with ARK purchasing 86,906 shares between the ARKK and ARKW ETFs, totaling $5,369,921. This investment decision could signal ARK's confidence in GitLab's innovative software development platform and its potential for growth. While ARK also engaged in smaller transactions, such as selling 154,32 shares of DraftKings Inc (NASDAQ:DKNG) and buying 122,649 shares of Absci Corp (NASDAQ:ABSI), every trade reflects the fund's continuous efforts to optimize its investment portfolio in response to market conditions and company performance. Reviewing ARK's trade history from the past week reveals a pattern of accumulating shares of GitLab Inc (NASDAQ:GTLB) and Tempus AI Inc (NYSE:TEM), suggesting a bullish stance on these companies. Conversely, a consistent sell-off in companies like Roku Inc (NASDAQ:ROKU) and UiPath Inc (NYSE:PATH) could point to a more bearish view or a reallocation of resources within ARK's diverse investment strategies. Investors and market observers will undoubtedly keep a close eye on ARK's trades as they provide insights into the investment firm's outlook and strategic positioning in the ever-evolving landscape of innovative and disruptive companies.

Cathie Wood Smelling AI Opportunity? Ark Invest Buys Tempus AI Dip, Scoops Up Over $13 M Worth Of Stock - ARK Genomic Revolution ETF (BATS:ARKG), ARK Innovation ETF (ARCA:ARKK)

On Thursday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc TEM and GitLab Inc GTLB. These trades reflect Ark's strategic positioning in the tech and AI sectors, following recent earnings reports from both companies. The Tempus AI Trade Ark Invest's ARK Innovation ETF ARKK acquired 225,833 shares of Tempus AI, while ARK Genomic Revolution ETF ARKG purchased 44,969 shares. The transactions were valued at $13.23 million. For the day, Tempus AI shares ended 7.9% lower at $48.86. These trades come after Tempus AI's recent quarterly earnings report, which showed a revenue miss but an earnings-per-share beat. The company reported fourth-quarter revenue of $200.68 million, falling short of the $203.12 million estimate. However, its adjusted loss of 18 cents per share was better than the anticipated 20-cent loss. Despite the mixed results, Tempus AI provided strong guidance. Analysts have varied opinions on Tempus AI, with some expressing bullish sentiments while others remaining cautious. The GitLab Trade On the same day, Ark Invest's ARKK and ARK Next Generation Internet ETF ARKW collectively purchased 86,906 shares of GitLab. This trade was valued at $5.06 million based on Thursday's closing price of $58.25. This move follows GitLab's impressive fourth-quarter earnings report, which exceeded expectations. GitLab reported earnings of 33 cents per share, surpassing the consensus estimate of 23 cents. Additionally, its revenue of $211.43 million beat the expected $206.12 million. Other Key Trades: Purchased Ibotta Inc. (IBTA) stock through ARKK and ARKF Purchased Recursion Pharmaceuticals Inc. (RXRX) shares through ARKG. Sold shares of Uipath Inc. (PATH) via ARKK and Draftkings Inc. (DKNG) through ARKW. ARKG sold Repare Therapeutics Inc. (RPTX) and Exact Sciences Corp. (EXAS) stock Image via Shutterstock Read Next: Trump Creates Strategic Bitcoin Reserve Funded By Forfeited Assets: 'I Made The Promise' -- BTC Dips 4% This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal ARKGARK Genomic Revolution ETF$23.20-3.25%OverviewARKKARK Innovation ETF$52.10-4.75%ARKWARK Next Generation Internet ETF$100.80-5.76%GTLBGitLab Inc$58.64-5.10%TEMTempus AI Inc$47.21-11.0%Market News and Data brought to you by Benzinga APIs